Free Trial

Exponent, Inc. (NASDAQ:EXPO) Shares Acquired by ProShare Advisors LLC

Exponent logo with Business Services background

ProShare Advisors LLC boosted its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 21.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 97,046 shares of the business services provider's stock after purchasing an additional 17,440 shares during the period. ProShare Advisors LLC owned about 0.19% of Exponent worth $8,647,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new position in shares of Exponent in the fourth quarter valued at approximately $55,131,000. Norges Bank acquired a new position in Exponent during the 4th quarter worth $52,381,000. Resona Asset Management Co. Ltd. purchased a new stake in Exponent during the 4th quarter worth about $38,538,000. BLI Banque de Luxembourg Investments purchased a new stake in Exponent during the 4th quarter worth about $12,564,000. Finally, Barclays PLC boosted its stake in shares of Exponent by 88.5% in the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock valued at $16,209,000 after buying an additional 85,395 shares during the period. Hedge funds and other institutional investors own 92.37% of the company's stock.

Exponent Trading Down 2.4%

Shares of EXPO stock traded down $1.92 on Wednesday, reaching $77.40. 226,159 shares of the stock were exchanged, compared to its average volume of 244,869. The company has a market capitalization of $3.93 billion, a price-to-earnings ratio of 36.51 and a beta of 0.95. The business's 50 day moving average price is $79.17 and its 200 day moving average price is $87.58. Exponent, Inc. has a twelve month low of $73.37 and a twelve month high of $115.75.

Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping the consensus estimate of $0.48 by $0.04. The company had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The firm's revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 earnings per share. Equities research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be given a $0.30 dividend. The ex-dividend date is Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a yield of 1.55%. Exponent's payout ratio is currently 58.54%.

Insiders Place Their Bets

In related news, VP Bradley A. James sold 2,694 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total value of $214,226.88. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Richard Reiss sold 1,736 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the transaction, the vice president now directly owns 1,800 shares of the company's stock, valued at $154,674. The trade was a 49.10% decrease in their position. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by company insiders.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines